190 related articles for article (PubMed ID: 6396565)
1. [Phase II study of the water-soluble nitrosourea compound ACNU in advanced colorectal carcinomas].
Fiebig HH; Wellens W; Peukert M; Henss H; Arnold H; Westerhausen M; Löhr GW
Onkologie; 1984 Dec; 7(6):370-7. PubMed ID: 6396565
[TBL] [Abstract][Full Text] [Related]
2. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancer.
Bedikian AY; Stroehlein JR; Karlin DA; Bennetts RW; Stewart DJ; Bodey GP
Am J Clin Oncol; 1983 Feb; 6(1):49-52. PubMed ID: 6837507
[TBL] [Abstract][Full Text] [Related]
3. PCNU: phase II evaluation in advanced colorectal carcinoma.
Pazdur R; Samson MK; Baker LH
Invest New Drugs; 1988 Jun; 6(2):93-5. PubMed ID: 3170134
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot study.
Earhart RH; Moertel C; Hahn RG; Woodhouse CL; Ramirez G; Engstrom PF
Am J Clin Oncol; 1984 Aug; 7(4):309-12. PubMed ID: 6741861
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of nimustine (ACNU; 3-[4-amino-2-methyl-5-pyrimidinyl) methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride) in patients with small cell carcinoma of the lung after failure on combination chemotherapy.
Joss RA; Siegenthaler P; Ludwig C; Alberto P; Castiglione MM; Cavalli F
Invest New Drugs; 1986; 4(2):175-9. PubMed ID: 3015827
[TBL] [Abstract][Full Text] [Related]
6. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
Cedermark BJ; Didolkar MS; Elias EG
Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose.
Fujimoto S; Wang Y; Ogawa M
Cancer Chemother Pharmacol; 1984; 12(3):173-8. PubMed ID: 6584235
[TBL] [Abstract][Full Text] [Related]
8. Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea.
Stroehlein JR; Bedikian AY; Karlin DA; Valdivieso M; Bennetts RW; Bodey GP
Am J Clin Oncol; 1982 Aug; 5(4):421-7. PubMed ID: 7113964
[TBL] [Abstract][Full Text] [Related]
9. Methyl-CCNU, 6-thioguanine, and 5-fluorouracil in advanced colorectal cancer.
Aroney RS; Dalley DN; Chan WK; Bell DR; Levi JA
Med Pediatr Oncol; 1981; 9(2):181-6. PubMed ID: 7231364
[TBL] [Abstract][Full Text] [Related]
10. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
Togni P; Sessa C; Varini M; Cavalli F
Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
[TBL] [Abstract][Full Text] [Related]
11. Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancer.
Belt RJ; Stephens R
Cancer; 1979 Sep; 44(3):869-72. PubMed ID: 383275
[TBL] [Abstract][Full Text] [Related]
12. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
[No Abstract] [Full Text] [Related]
13. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
Posey LE; Morgan LR
Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of ACNU as second-line treatment in small-cell lung cancer. EORTC Lung Cancer Cooperative Group.
Planting AS; Splinter TA; Ardizzoni A; Estapé J; Giaccone G; Kirkpatrick A; Dalesio O; McVie JG
Cancer Chemother Pharmacol; 1992; 29(5):409-11. PubMed ID: 1312909
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
Machover D; Goldschmidt E; Chollet P; Metzger G; Zittoun J; Marquet J; Vandenbulcke JM; Misset JL; Schwarzenberg L; Fourtillan JB
J Clin Oncol; 1986 May; 4(5):685-96. PubMed ID: 3517242
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of doxifluridine in advanced colorectal adenocarcinoma.
Abele R; Alberto P; Kaplan S; Siegenthaler P; Hofmann V; Ryssel HJ; Hartmann D; Holdener EE; Cavalli F
J Clin Oncol; 1983 Dec; 1(12):750-4. PubMed ID: 6230419
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancer.
Rubin J; Schutt AJ; O'Connell MJ; Gertz MA; Moertel CG
Am J Clin Oncol; 1984 Oct; 7(5):523-5. PubMed ID: 6507373
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer.
Buroker T; Wojtaszak B; Dindogru A; DeMattia M; Baker L; Groth C; Vaitkevicius VK
Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398
[TBL] [Abstract][Full Text] [Related]
19. [Intensive 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) and cryopreserved autologous bone marrow transplantation].
Sampi K; Kumai R; Yanagawa S; Hattori M
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2339-41. PubMed ID: 3044278
[No Abstract] [Full Text] [Related]
20. [Pancreatic and biliary excretion of 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) in man].
Matsuno S; Kakizaki K; Sasaki K; Sato T
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1486-90. PubMed ID: 6575728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
